Serum resistin: A possible link between inflammation, hypertension and coronary artery disease

Sobia Niaz1, Javaria Latif2, Shaista Hussain3

  • 1Sobia Niaz, Assistant Professor, Department of Physiology, Fatima Memorial Hospital College of Medicine & Dentistry, Lahore, Pakistan.

Insights

Serum resistin, C-reactive protein, and total leukocyte count are elevated in hypertension and coronary artery disease patients. Resistin correlated with leukocyte count in myocardial infarction patients.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Biochemistry

Background:

  • Inflammation is a key factor in atherosclerosis, hypertension, and coronary artery disease.
  • Resistin, an inflammatory cytokine, mediates these conditions.
  • Understanding resistin's role is crucial for cardiovascular disease management.

Purpose of the Study:

  • To compare serum resistin, C-reactive protein (CRP), and total leukocyte count (TLC) in hypertension and coronary artery disease (CAD) patients.
  • To investigate the correlation between serum resistin and CRP/TLC in these patient groups.

Main Methods:

  • Eighty participants were categorized into four groups: healthy, hypertension, stable angina, and myocardial infarction (MI) with hypertension.
  • Serum resistin and CRP were measured using ELISA.
  • Total leukocyte count was determined using an automated hematology analyzer.

Main Results:

  • Serum resistin, CRP, and TLC were significantly higher in all patient groups compared to healthy controls (p<0.001).
  • A significant positive correlation between resistin and TLC was found only in hypertensive MI patients (r=0.459, p=0.042).
  • No significant correlation was observed between resistin and TLC or CRP in other groups.

Conclusions:

  • Serum resistin, CRP, and TLC are elevated in patients with hypertension and coronary artery disease.
  • Resistin shows a significant positive correlation with TLC specifically in hypertensive patients with myocardial infarction.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
912
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
390
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
222
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
342
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
606
Inflammation01:38

Inflammation

Overview
61.8K